Ameritas Investment Partners, Inc. - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 61 filers reported holding IMMUNE DESIGN CORP in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$17,000
+325.0%
2,9480.0%0.00%
Q4 2018$4,000
-60.0%
2,9480.0%0.00%
Q3 2018$10,000
-23.1%
2,9480.0%0.00%
-100.0%
Q2 2018$13,000
+333.3%
2,948
+237.3%
0.00%
Q1 2018$3,0000.0%8740.0%0.00%
Q4 2017$3,000
-66.7%
8740.0%0.00%
Q3 2017$9,0000.0%8740.0%0.00%
Q2 2017$9,000
+50.0%
8740.0%0.00%
Q1 2017$6,0008740.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2017
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders